Pascal Wang Emmanuelle Fabre Antoine Martin Kader Chouahnia Ambre Benabadji Lise Matton Boris Duchemann
10.3389/fonc.2022.918855
Front Oncol
2022 Jul 25;12:918855.
egfr nsclc compound mutations exon 18 tyrosine kinase inhibitor (tki) uncommon mutation
CC BY
https://pubmed.ncbi.nlm.nih.gov/35957870/
Case Reports
PMC9358716
35957870
Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18-18 and EGFR amplification: A case report
2022